Annual Total Long Term Liabilities
$91.46 M
+$9.11 M+11.06%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual total long term liabilities is $91.46 million, with the most recent change of +$9.11 million (+11.06%) on December 31, 2023.
- During the last 3 years, TCRX annual total long term liabilities has risen by +$16.71 million (+22.35%).
- TCRX annual total long term liabilities is now at all-time high.
Performance
TCRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$90.28 M
+$9.20 M+11.35%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly total long term liabilities is $90.28 million, with the most recent change of +$9.20 million (+11.35%) on September 30, 2024.
- Over the past year, TCRX quarterly long term liabilities has increased by +$1.01 million (+1.13%).
- TCRX quarterly long term liabilities is now -47.52% below its all-time high of $172.02 million, reached on March 31, 2021.
Performance
TCRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TCRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.1% | +1.1% |
| 3 y3 years | +22.4% | +1.1% |
| 5 y5 years | +42.6% | +1.1% |
TCRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1427.9% | -1.3% | +2412.7% |
| 5 y | 5-year | at high | +1427.9% | -47.5% | +2412.7% |
| alltime | all time | at high | +1427.9% | -47.5% | +2412.7% |
TScan Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $90.28 M(+11.3%) |
| Jun 2024 | - | $81.08 M(-6.1%) |
| Mar 2024 | - | $86.39 M(-5.5%) |
| Dec 2023 | $91.46 M(+11.1%) | $91.46 M(+2.5%) |
| Sep 2023 | - | $89.27 M(-2.1%) |
| Jun 2023 | - | $91.20 M(+11.9%) |
| Mar 2023 | - | $81.51 M(-1.0%) |
| Dec 2022 | $82.35 M | $82.35 M(+155.7%) |
| Sep 2022 | - | $32.20 M(+796.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $3.59 M(-11.2%) |
| Mar 2022 | - | $4.04 M(-32.4%) |
| Dec 2021 | $5.99 M(-92.0%) | $5.99 M(-23.9%) |
| Sep 2021 | - | $7.87 M(-95.4%) |
| Jun 2021 | - | $169.42 M(-1.5%) |
| Mar 2021 | - | $172.02 M(+130.1%) |
| Dec 2020 | $74.75 M(+16.6%) | - |
| Dec 2020 | - | $74.75 M |
| Dec 2019 | $64.13 M | - |
FAQ
- What is TScan Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for TScan Therapeutics?
- What is TScan Therapeutics annual total long term liabilities year-on-year change?
- What is TScan Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for TScan Therapeutics?
- What is TScan Therapeutics quarterly long term liabilities year-on-year change?
What is TScan Therapeutics annual total long term liabilities?
The current annual total long term liabilities of TCRX is $91.46 M
What is the all time high annual total long term liabilities for TScan Therapeutics?
TScan Therapeutics all-time high annual total long term liabilities is $91.46 M
What is TScan Therapeutics annual total long term liabilities year-on-year change?
Over the past year, TCRX annual total long term liabilities has changed by +$9.11 M (+11.06%)
What is TScan Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of TCRX is $90.28 M
What is the all time high quarterly long term liabilities for TScan Therapeutics?
TScan Therapeutics all-time high quarterly total long term liabilities is $172.02 M
What is TScan Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, TCRX quarterly total long term liabilities has changed by +$1.01 M (+1.13%)